More meeting highlights from ASCO in cancer prevention, diagnosis, and treatment--in case your patient asks.
Cancer is such a ruthless adversary because it behaves as if it has its own fiendishly cunning agenda.-Physicist Paul Davies
Physicians support the concept of multdisciplinary care for lung cancer patients but have reservations about widespread implementation.
Quality of end of life care for cancer patients varies widely and by type of cancer. New approaches are sorely needed.
Immunotherapy for bladder cancer with PD-L1 antibody extended survival by approximately 4 to 5 months.
An additional 5 years of aromatase inhibitor therapy for women with breast cancer reduced recurrence by 34% vs placebo.
Following USPSTF guidance on limiting PSA screening has led to increased diagnoses of high-grade disease and increased cost of care.
Combination IV and IP chemotherapy for ovarian cancer slowed disease progression vs IV therapy alone.
Women who overestimated risk of breast cancer recurrence, despite favorable prognosis, had reduced quality of life.
Researchers and educators at the 2016 American Society of Clinical Oncology Annual Meeting, held recently in Chicago, presented the latest advances in cancer prevention, diagnosis, and treatment.Part 1 of this slideshow, “If Your Patient Asks About Cancer: 9 New Facts,” described cancer studies and advances of interest to primary care physicians.Click above for brief summaries of more of these noteworthy cancer developments.